Invesaro

Stocks Comparison

Avanos Medical vs Zimmer Biomet: revenue, profit, margins and growth compared

Avanos Medical brought in $701.2M of revenue in fiscal 2025, Zimmer Biomet $8.2B in fiscal 2025. Revenue changed by +1.9% at Avanos Medical and +7.2% at Zimmer Biomet on the year before, so Zimmer Biomet grew faster. Avanos Medical kept -10.4% of its revenue as net profit, Zimmer Biomet 8.6%. Free cash flow was $43.1M at Avanos Medical and $1.5B at Zimmer Biomet.

Side by side, latest fiscal year

AVNSZBH
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$701.2M$8.2B
Revenue growth+1.9%+7.2%
Net income-$72.9M$705.1M
Net margin-10.4%8.6%
Free cash flow$43.1M$1.5B
Free cash flow margin6.1%17.9%
Earnings per share (diluted)-$1.57$3.55
Cash$89.8M$591.9M
Debt$90.3M$7.5B
Price to earningsn/a25.6
Market valuen/a$17.4B
Dividend yieldn/a1.05%
Rank by revenue in sector#175 of 646 · Health care#52 of 646 · Health care

Over the years

Revenue
AVNS FY2018: $652.3MAVNS FY2019: $697.6MAVNS FY2020: $714.8MAVNS FY2021: $587MAVNS FY2022: $684.1MAVNS FY2023: $673.3MAVNS FY2024: $687.8MAVNS FY2025: $701.2MZBH FY2018: $7.9BZBH FY2019: $8BZBH FY2020: $6.1BZBH FY2021: $6.8BZBH FY2022: $6.9BZBH FY2023: $7.4BZBH FY2024: $7.7BZBH FY2025: $8.2BFY18FY19FY20FY21FY22FY23FY24FY25
AVNS $701.2MZBH $8.2B
Net income
AVNS FY2018: $57.5MAVNS FY2019: -$45.9MAVNS FY2020: -$29MAVNS FY2021: $6.3MAVNS FY2022: $50.5MAVNS FY2023: -$61.8MAVNS FY2024: -$392.1MAVNS FY2025: -$72.9MZBH FY2018: -$379.2MZBH FY2019: $1.1BZBH FY2020: -$138.9MZBH FY2021: $401.6MZBH FY2022: $231.4MZBH FY2023: $1BZBH FY2024: $903.8MZBH FY2025: $705.1MFY18FY19FY20FY21FY22FY23FY24FY25
AVNS -$72.9MZBH $705.1M
Net margin
AVNS FY2018: 8.8%AVNS FY2019: -6.6%AVNS FY2020: -4.1%AVNS FY2021: 1.1%AVNS FY2022: 7.4%AVNS FY2023: -9.2%AVNS FY2024: -57.0%AVNS FY2025: -10.4%ZBH FY2018: -4.8%ZBH FY2019: 14.2%ZBH FY2020: -2.3%ZBH FY2021: 5.9%ZBH FY2022: 3.3%ZBH FY2023: 13.8%ZBH FY2024: 11.8%ZBH FY2025: 8.6%FY18FY19FY20FY21FY22FY23FY24FY25
AVNS -10.4%ZBH 8.6%
Revenue growth
AVNS FY2019: +6.9%AVNS FY2020: +2.5%AVNS FY2021: -17.9%AVNS FY2022: +16.5%AVNS FY2023: -1.6%AVNS FY2024: +2.2%AVNS FY2025: +1.9%ZBH FY2019: +0.6%ZBH FY2020: -23.2%ZBH FY2021: +11.4%ZBH FY2022: +1.6%ZBH FY2023: +6.5%ZBH FY2024: +3.8%ZBH FY2025: +7.2%FY19FY20FY21FY22FY23FY24FY25
AVNS +1.9%ZBH +7.2%
Free cash flow
AVNS FY2018: -$194.7MAVNS FY2019: -$125.1MAVNS FY2020: -$22.7MAVNS FY2021: $66.3MAVNS FY2022: $71.6MAVNS FY2023: $14.6MAVNS FY2024: $82.9MAVNS FY2025: $43.1MZBH FY2018: $1.6BZBH FY2019: $1.4BZBH FY2020: $1.1BZBH FY2021: $1.4BZBH FY2022: $1.2BZBH FY2023: $1.3BZBH FY2024: $1.3BZBH FY2025: $1.5BFY18FY19FY20FY21FY22FY23FY24FY25
AVNS $43.1MZBH $1.5B

Fiscal years as each company reports them; the two may end in different months.

Questions about Avanos Medical and Zimmer Biomet

Which is bigger by revenue, Avanos Medical or Zimmer Biomet?

Zimmer Biomet is bigger by revenue: $8.2B in fiscal 2025, against $701.2M for Avanos Medical in fiscal 2025.

Which keeps more of its revenue as profit, Avanos Medical or Zimmer Biomet?

Avanos Medical had a net margin of -10.4% in fiscal 2025; Zimmer Biomet had 8.6% in fiscal 2025.

Which grew revenue faster, Avanos Medical or Zimmer Biomet?

In their latest fiscal years revenue changed by +1.9% at Avanos Medical and +7.2% at Zimmer Biomet.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies